期刊论文详细信息
World Allergy Organization Journal
Clinical Efficacy and Safety of a Combined Loratadine-Betamethasone Oral Solution in the Treatment of Severe Pediatric Perennial Allergic Rhinitis
Francis Sánchez2  Teolinda Mendoza de Morales1 
[1] Instituto de Otorrinolaringologia San Bernardino, Caracas, Venezuela;Policlinica Metropolitana, Caracas, Venezuela
关键词: quality of life;    perennial allergic rhinitis;    pediatric;    loratadine;    etamethasone;   
Others  :  1180893
DOI  :  10.1097/WOX.0b013e31819f2105
PDF
【 授权许可】

   
2009 World Allergy Organization; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150514101636952.pdf 344KB PDF download
【 参考文献 】
  • [1]Carrasco E: Epidemiologic aspects of asthma in Latin America. Chest 1987, 91(June 1):93S-97S.
  • [2]Perdomo de Ponce D, Uribe M, Wolff I: Allergic and nonallergic rhinitis: their characterization in a tropical environment. Invest Clin 1990, 31(3):129-138.
  • [3]Berger WE: Allergic rhinitis in children: diagnosis and management strategies. Paediatr Drugs 2004, 6(4):233-250.
  • [4]Blaiss MS, The Allergic Rhinitis in Schoolchildren Consensus Group: Allergic rhinitis and impairment issues in schoolchildren: a consensus report. Curr Med Res Opin 2004, 20(12):1937-1952.
  • [5]International Conference on Allergic Rhinitis in Childhood Allergy 1999, 54(suppl 55):4-34.
  • [6]Sibbald B: Epidemiology of allergic rhinitis. In Epidemiology of Clinical Allergy: Monographs in Allergy. Edited by Burr ML. Basel, Switzerland: Karger; 1993:61-79.
  • [7]Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A: Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol 2007, 120(2):381-387.
  • [8]Meltzer EO, Nathan RA, Selner JC, Storms W: Quality of life and rhinitic symptoms: results of a nationwide survey with the SF-36 and RQLQ questionnaires. J Allergy Clin Immunol 1997, 99(6, suppl 1):815-819.
  • [9]Tanner LA, Reilly M, Meltzer EO, Bradford JE, Mason J: Effect of fexofenadine HCl on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis. Am J Manag Care 1999, 5(4, suppl II):S235-S247.
  • [10]Fireman P: Therapeutic approaches to allergic rhinitis: treating the child. J Allergy Clin Immunol 2000, 105(6, suppl 1):616-621.
  • [11]Bousquet J, van Cauwenberge P, Khaltaev N, for the ARIA Workshop Group and the World Health Organization: Allergic rhinitis and its impact on asthma: ARIA Workshop Report. J Allergy Clin Immunol 2001, 108(5):S147-S334.
  • [12]Bellanti JA, Wallerstedt DB: Allergic rhinitis update: epidemiology and natural history. Allergy Asthma Proc 2000, 21(6):367-370.
  • [13]Skoner DP: Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001, 108(1):S2-S8.
  • [14]Juniper EF: Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 1997, 99(2):S742-S749.
  • [15]Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, et al.: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and Aller-Gen). Allergy 2008, 63(suppl 86):8-160.
  • [16]van Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, Canonica GW, et al.: Consensus statement on the treatment of allergic rhinitis. Allergy 2000, 55(2):116-134.
  • [17]Bruttmann G, Charpin D, Germouty J, Horak F, Kunkel G: Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis. J Allergy Clin Immunol 1989, 83(2 Pt 1):411-416.
  • [18]Frølund L, Etholm B, Irander K, Johannessen TA, Odkvist L, et al.: A multicentre study of loratadine, clemastine and placebo in patients with perennial allergic rhinitis. Allergy 1990, 45(4):254-261.
  • [19]Boner AL, Richelli C, Castellani C, Marchesi E, Andreoli A: Comparison of the effects of loratadine and astemizole in the treatment of children with seasonal allergic rhinoconjunctivitis. Allergy 1992, 47(2 Pt 1):98-102.
  • [20]Boner AL, Miglioranzi P, Richelli C, Marchesi E, Andreoli A: Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis. Allergy 1989, 44(6):437-441.
  • [21]Salmun LM, Herron JM, Banfield C, Padhi D, Lorber R, Affrime MB: The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years. Clin Ther 2000, 22(5):613-621.
  • [22]Harding SM, Heath S: Intranasal steroid aerosol in perennial rhinitis: comparison with an antihistamine compound. Clin Allergy 1976, 6(4):369-372.
  • [23]Edwards TB: Effectiveness and safety of beclomethasone dipropionate, an intranasal corticosteroid, in the treatment of patients with allergic rhinitis. Clin Ther 1995, 17(6):1032-1041.
  • [24]Juniper EF: Rhinitis management: the patient's perspective. Clin Exp Allergy 1998, 28(S6):34-38.
  • [25]Richards W: Preventing behavior problems in asthma and allergies. Clin Pediatr 1994, 33(10):617-624.
  • [26]Gentile DA, Friday GA, Skoner DP: Management of allergic rhinitis: antihistamines and decongestants. Immunol Allergy Clin North Am 2000, 20(2):355-368.
  • [27]Patou J, De Smedt H, van Cauwenberge P, Bachert C: Pathophysiology of nasal obstruction and meta-analysis of early and late effects of levocetirizine. Clin Exp Allergy 2006, 36(8):972-981.
  • [28]Snyman JR, Potter PC, Groenewald M, Levin J, for the Claricort Study Group: Effect of betamethasone-loratadine combination therapy on severe exacerbations of allergic rhinitis: a randomised, controlled trial. Clin Drug Investig 2004, 24(5):265-274.
  • [29]Anolik R, for the Mometasone Furoate Nasal Spray with Loratadine Study Group: Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2008, 100(3):264-271.
  • [30]Ratner PH, van Bavel JH, Martin BG, Hampel FC Jr, Howland WC, et al.: A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. J Fam Pract 1998, 47(2):118-125.
  • [31]Lutsky BN, Klöse P, Melon J, Menardo JL, Molkhou P, et al.: A comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension in the treatment of 3- to 6-year-old children with seasonal allergic rhinitis. Clin Ther 1993, 15(5):855-865.
  • [32]Yang YH, Lin YT, Lu MY, Tsai MJ, Chiang BL: A double-blind, placebo-controlled, and randomized study of loratadine (Clarityne) syrup for the treatment of allergic rhinitis in children aged 3 to 12 years. Asian Pac J Allergy Immunol 2001, 19(3):171-175.
  • [33]Diaz-Sanchez D, Tsien A, Fleming J, Saxon A: Effect of topical fluticasone propionate on the mucosal allergic response induced by ragweed allergen and diesel exhaust particle challenge. Clin Immunol 1999, 90(3):313-322.
  • [34]Tillmann HC, Stuck BA, Feuring M, Rossol-Haseroth K, Tran BM, et al.: Delayed genomic and acute nongenomic action of glucocorticosteroids in seasonal allergic rhinitis. Eur J Clin Invest 2004, 34(1):67-73.
  文献评价指标  
  下载次数:5次 浏览次数:11次